Au, R., Piers, R. J. & Lancashire, L. Back to the future: Alzheimer’s disease heterogeneity revisited. Alzheimers Dement (Amst) 1, 368–370 (2015).
Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–3 (1993).
Corder, E. H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7, 180–4 (1994).
Seshadri, S., Drachman, D. A. & Lippa, C. F. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer’s disease. What physicians know, and what they should know. Arch Neurol 52, 1074–9 (1995).
van der Lee, S. J. et al. The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia: a community-based cohort study. Lancet Neurol 17, 434–444 (2018).
Fernandez, C. G., Hamby, M. E.,…
